Professor Kai Blennow discusses the value of blood and cerebrospinal fluid biomarkers in Alzheimer’s disease, highlighting their potential applications in diagnostics, research studies, clinical trials and primary care. To find out more, visit [ Ссылка ]
Connect with us
Visit us on: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
